Infection Testing
SARS Viral Load Quantitative Test
The SARS Viral Load Quantitative Test measures the amount of SARS virus in your body. It helps monitor infection severity and response to treatment. Essential for symptomatic patients or those at risk.
General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.
Review status: No completed medical review is recorded for this page.
At a glance
Plan your test
- Sample
- Bronchial Swabs, Bronchial Lavage
- Results
- Results are typically available within 36 hours via email and 24 hours via phone. Confirm with the laboratory before booking.
- Preparation
- Patients are required to sign a consent document and provide relevant clinical history related to the test.
Payment: M-Pesa and card options can be confirmed during booking.
Insurance & government schemes
Is this test covered for you?
We help you verify whether the SARS Viral Load Quantitative Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.
Providers & schemes we can help you check
Government & public schemes
Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.
Private insurers & employer schemes
Names shown for identification only — listing does not imply partnership or guarantee of coverage.
Have these ready when we check
- Insurer or scheme name & policy / member number
- A clinician's request / prescription for the test
- Pre-authorisation letter, if your plan requires one
Free coverage check
Ask us to verify your cover
Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.
Start with fit
Is this the right test for you?
The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.
- ✓Patients showing symptoms consistent with SARS.
- ✓Individuals with known exposure to SARS.
- ✓Patients at high risk due to underlying health conditions.
- ✓Patients undergoing SARS treatment requiring viral load monitoring.
- ✓Assessment of disease severity.
- ✓Evaluation of treatment response.
In plain language
What this test helps you understand
This test quantifies the viral load of the SARS virus in the patient's sample. It determines the number of viral particles present, which is crucial for assessing the progression of the disease and the effectiveness of antiviral therapies.
Individuals who may need to undergo the SARS Viral Load Quantitative Test include:
* Patients exhibiting symptoms of SARS, such as fever, cough, and difficulty breathing. * Individuals with a known exposure to SARS or those at high risk due to underlying health conditions. * Patients undergoing treatment for SARS who require monitoring of their viral load.
Taking the SARS Viral Load Quantitative Test offers several benefits:
* Accurate measurement of viral load to guide treatment decisions. * Early detection of viral replication, which can be critical for timely intervention. * Monitoring the effectiveness of antiviral therapy over time. * Providing reassurance and clarity for patients and their families.
Results from the SARS Viral Load Quantitative Test will indicate the level of virus present in your sample. Generally, higher viral loads may suggest a more severe infection, while lower levels may indicate a better response to treatment. It is important to discuss your results with your physician to understand their implications fully.
Medical review status
Clinical review pending
A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.
Meet the DNA Labs Kenya medical team →A simple process
What happens next?
You do not have to navigate the test alone. We help you move from question to next step.
Speak with us
We check the test and answer your questions before collection.
Give your sample
Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.
Understand your report
A counselor helps you understand the result and the next steps.
Choose your collection
Home collection or a lab visit
We will explain the sample, preparation, and next steps before anything is collected.
Home collection
Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.
Lab or hub visit
Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.
Ask about locations →Read your report
What common result terms mean
Questions people ask
Frequently asked questions
Collaboration
Open for partnership with hospitals, clinics, doctors & researchers
Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.
Hospitals & clinics
Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.
Doctors & specialists
LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.
Research institutions
Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.
Students & academic projects
Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.
Trust & transparency
Sources, standards & how this page is maintained
Standards & references
- ACMG/AMP technical standards for sequence variant interpretation
- ClinGen curation and gene–disease validity frameworks where applicable
- LOINC-coded reporting for interoperable results
- ISO 9001:2015 quality management; ISO 15189 accreditation in progress
Page provenance
- Last updated: September 27, 2026
- Medical review: not yet completed
- Written for patients & clinicians in Kenya; reviewed periodically against current guidance
Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.
Keep exploring
Related tests
1 3BetaDGlucan BDG Test
The 1 3BetaDGlucan BDG Test helps detect fungal infections by measuring beta-glucan levels in the blood. It is particularly useful for individuals with weakened immune systems or symptoms suggesting a fungal infection.
Learn more →Chlamydia IgG Antibody Panel Test
Detects past exposure to Chlamydia trachomatis and Chlamydophila pneumoniae infections by measuring IgG antibodies in the blood. Helps identify potential health risks.
Learn more →Dengue Fever IgG Antibody Test
The Dengue Fever IgG Antibody Test detects antibodies indicating a past dengue virus infection. It helps assess immunity and understand previous exposure.
Learn more →Chlamydophila Pneumoniae IgG Test
This test detects IgG antibodies to Chlamydophila pneumoniae, indicating a past infection with this bacterium, which can cause respiratory illnesses.
Learn more →